Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
A study to evaluate the safety and tolerability and pharmacokinetics of ACT001 in children with advanced brain and solid tumors
Protocol ID
ACT001-AU-002
Disease (Sub Disease)
Advanced brain tumour
Advanced solid tumour
Advanced solid tumour
Diagnosis Stage
Relapse/refractory
Location
NSW, QLD
Sponsor
Accendatech AU Pty Ltd
CPR Pharma Services Pty Ltd
CPR Pharma Services Pty Ltd
Links
Trial Status
Open
Sites
Perth Children's Hospital
Queensland Children's Hospital
Sydney Children's Hospital
Queensland Children's Hospital
Sydney Children's Hospital
Study Type
Treatment
Phase
Phase 1
Age Eligibility
1 Year to 21 Years
ANZCTR
ACTRN12618001934235
| Study Title | A study to evaluate the safety and tolerability and pharmacokinetics of ACT001 in children with advanced brain and solid tumors |
|---|---|
| Protocol ID | ACT001-AU-002 |
| Disease (Sub Disease) | Advanced brain tumour Advanced solid tumour |
| Diagnosis Stage | Relapse/refractory |
| Location | NSW / QLD |
| Sponsor | Accendatech AU Pty Ltd / CPR Pharma Services Pty Ltd/ |
| Links | https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=376262&isReview=true |
| Trial Status | Open |
| Trial Open Date | 18/09/2019 |
| Sites | Perth Children's Hospital / Queensland Children's Hospital / Sydney Children's Hospital/ |
| Study Type | Treatment |
| Phase | Phase 1 |
| Age Eligibility | 1 Year to 21 Years |
| ANZCTR | ACTRN12618001934235 |